Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Helena Sjödin"'
Autor:
Lars Axelsson, Erik Holmberg, Jan Nyman, Anders Högmo, Helena Sjödin, Maria Gebre-Medhin, Mathias von Beckerath, Tomas Ekberg, Lisa Farnebo, Charbel Talani, Lena Norberg Spak, Isak Notstam, Eva Hammerlid
Publikováno v:
International Archives of Otorhinolaryngology, Vol 25, Iss 03, Pp e433-e442 (2021)
Introduction Head and neck cancer of unknown primary (HNCUP) is a rare condition whose prognostic factors that are significant for survival vary between studies. No randomized treatment study has been performed thus far, and the optimal treatment is
Externí odkaz:
https://doaj.org/article/87da7237850447208eeabd7a33eae8a6
Autor:
Eva Onjukka, Claes Mercke, Einar Björgvinsson, Anna Embring, Anders Berglund, Gabriella Alexandersson von Döbeln, Signe Friesland, Giovanna Gagliardi, Clara Lenneby Helleday, Helena Sjödin, Ingmar Lax
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
AimData from a local quality registry are used to model the risk of late xerostomia after radiotherapy for head and neck cancer (HNC), based on dosimetric- and clinical variables. Strengths and weaknesses of using quality registry data are explored.M
Externí odkaz:
https://doaj.org/article/a4c1aa59a7034c27a961031ecebc0fdd
Autor:
Malin Berg, Hedda Haugen Cange, Swedish Head, Anders Högmo, Maria Gebre-Medhin, Eva Hammerlid, Isak Notstam, Neck Cancer Register, Lovisa Farnebo, Göran Laurell, Erik Holmberg, Johan Reizenstein, Helena Sjödin, Lena Spaak Norberg, Ali Adnan
Publikováno v:
Head & Neck. 43:3843-3856
Background: This exploratory, registry-based, cross-sectional study aimed to evaluate patients' health-related quality of life (HRQOL) in a subsite of oropharyngeal cancer: cancer of the base of the tongue (CBT). Methods: CBT patients, treated with c
Autor:
Claes Mercke, Gun Wickart-Johansson, Helena Sjödin, Pedro Farrajota Neves da Silva, Gabriella Alexandersson von Döbeln, Gregori Margolin, Sara Jonmarker Jaraj, Hanna Carstens, Anders Berglund, Ingmar Lax, Mats Hellström, Lalle Hammarstedt-Nordenvall, Signe Friesland
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2543
The leading cause of death for patients with HPV associated squamous cell carcinoma of the head and neck (SCCHN) after treatment with chemoradiotherapy (CRT) nowadays is peripheral metastasis. This study investigated whether induction chemotherapy (I
Autor:
Anders Högmo, Erik Holmberg, Hedda Haugen Cange, Johan Reizenstein, Johan Wennerberg, Martin Beran, Karin Söderkvist, Eva Hammerlid, Helena Sjödin, Lovisa Farnebo, Karl Sandström, Lalle Hammarstedt-Nordenvall, Katarina Zborayova, Eva Brun
Background: The base of tongue squamous cell carcinoma (BOTSCC) is mainly an HPV-related tumor. Radiotherapy (EBRT) ± concomitant chemotherapy (CT) is the backbone of the curatively intended treatment, with brachytherapy (BT) boost as an option. Wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff42158e9ed87226a9f78ca971d0e29c
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-192521
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-192521
Autor:
Johan Wennerberg, Maria Gebre-Medhin, Per Nilsson, Eva Brun, Elisabeth Kjellén, Kristin Carlwig, Johan Reizenstein, Stefan Kristiansson, Karin Söderkvist, Magnus Wahlgren, Björn Zackrisson, Anders Högmo, Lalle Hammarstedt-Nordenvall, Helena Sjödin, Gun Wickart-Johansson, Lovisa Farnebo, Jan Rzpecki, Britta Lödén, Lena Cederblad, Tomas Ekberg, Stefan Bergström
Background and purpose An earlier prospective randomised multicentre study (ARTSCAN) in head and neck cancer patients that compared conventionally fractionated radiotherapy (CF) with accelerated radiotherapy (AF) was inconclusive. In the subgroup of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1c73aa9ec39a415e70fd561bea6806c
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-191960
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-191960
Autor:
Eva Hammerlid, Mathias von Beckerath, Tomas Ekberg, L. Axelsson, Isak Notstam, Erik Holmberg, Maria Gebre-Medhin, Lisa Farnebo, Helena Sjödin, Jan Nyman, Lena Spaak Norberg, Anders Högmo, Charbél Talani
Publikováno v:
International Archives of Otorhinolaryngology, Vol 25, Iss 03, Pp e433-e442 (2021)
International Archives of Otorhinolaryngology v.25 n.3 2021
International Archives of Otorhinolaryngology
Fundação Otorrinolaringologia (FORL)
instacron:FORL
International Archives of Otorhinolaryngology, Volume: 25, Issue: 3, Pages: 433-442, Published: 13 SEP 2021
International Archives of Otorhinolaryngology v.25 n.3 2021
International Archives of Otorhinolaryngology
Fundação Otorrinolaringologia (FORL)
instacron:FORL
International Archives of Otorhinolaryngology, Volume: 25, Issue: 3, Pages: 433-442, Published: 13 SEP 2021
Introduction Head and neck cancer of unknown primary (HNCUP) is a rare condition whose prognostic factors that are significant for survival vary between studies. No randomized treatment study has been performed thus far, and the optimal treatment is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5145ae4ff70650a584a580b9ac8ce359
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-454515
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-454515
Autor:
Karin Söderkvist, Maria Gebre-Medhin, Helena Sjödin, Per Nilsson, Edvard Abel, Signe Friesland, Björn Zackrisson, Lalle Hammarstedt-Nordenvall, Marcus Thomasson, Johan Reizenstein, Jan Nyman, Per Engström, Eva Brun, Hedda Haugen Cange, Henrik Carlsson
PURPOSE We performed an open-label randomized controlled phase III study comparing treatment outcome and toxicity between radiotherapy (RT) with concomitant cisplatin versus concomitant cetuximab in patients with locoregionally advanced head and neck
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c03c4f234b34ae2805369c72be7e81e4
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-180670
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-180670
Autor:
Ali Adnan, Isak Notstam, Eva Hammerlid, Lena Spaak Norberg, Anders Högmo, Helena Sjödin, Maria Gebre-Medhin, Johan Reizenstein, Göran Laurell, Lovisa Farnebo, Erik Holmberg, Hedda Haugen Cange
Publikováno v:
HeadneckREFERENCES. 42(5)
Background: The health-related quality of life (HRQOL) of tonsillar carcinoma survivors was explored to investigate any HRQOL differences associated with tumor stage and treatment. The survivors' HRQOL was also compared to reference scores from the p
Autor:
Britta Lödén, Lars Franzén, E. Persson, Anders Ask, Hans Modig, Gun Wickart-Johansson, Ove Björ, Claes Mercke, Lena Wittgren, Helena Sjödin, Elisabeth Kjellén, Per Nilsson, Eva Brun, Signe Friesland, Freddi Lewin, Karl-Axel Johansson, Thomas Björk-Eriksson, Jan-Olof Fernberg, Björn Zackrisson, Lars Ekberg, Jan Nyman, Johan Reizenstein
Publikováno v:
Radiotherapy and Oncology. 100:41-48
Background and purpose: Studies on accelerated fractionation (AF) in head and neck cancer have shown increased local control and survival compared with conventional fractionation (CF), while others have been non-conclusive. In 1998 a national Swedish